SWK Holdings Co. (NASDAQ:SWKH) Shares Purchased by Barclays PLC

Barclays PLC boosted its stake in shares of SWK Holdings Co. (NASDAQ:SWKH) by 185.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 4,461 shares of the company’s stock after purchasing an additional 2,896 shares during the period. Barclays PLC’s holdings in SWK were worth $77,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SWKH. Bank of New York Mellon Corp purchased a new position in shares of SWK during the 2nd quarter valued at approximately $172,000. Dimensional Fund Advisors LP lifted its position in shares of SWK by 85.7% in the second quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock valued at $511,000 after acquiring an additional 13,892 shares in the last quarter. SkyView Investment Advisors LLC boosted its stake in shares of SWK by 7.7% in the second quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company’s stock worth $529,000 after acquiring an additional 2,234 shares during the last quarter. Finally, Victory Capital Management Inc. purchased a new stake in shares of SWK during the third quarter worth approximately $589,000. 99.27% of the stock is owned by institutional investors and hedge funds.

SWK Stock Down 1.0 %

NASDAQ SWKH opened at $16.31 on Friday. SWK Holdings Co. has a one year low of $15.14 and a one year high of $18.49. The company has a debt-to-equity ratio of 0.11, a quick ratio of 5.06 and a current ratio of 5.06. The business has a fifty day moving average price of $16.10 and a 200 day moving average price of $16.69. The company has a market cap of $199.47 million, a P/E ratio of 17.54 and a beta of 0.36.

About SWK

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.